Literature DB >> 7538140

A conserved epitope on a subset of SR proteins defines a larger family of Pre-mRNA splicing factors.

K M Neugebauer1, J A Stolk, M B Roth.   

Abstract

The removal of introns from eukaryotic pre-mRNA occurs in a large ribonucleoprotein complex called the spliceosome. We have generated a monoclonal antibody (mAb 16H3) against four of the family of six SR proteins, known regulators of splice site selection and spliceosome assembly. In addition to the reactive SR proteins, SRp20, SRp40, SRp55, and SRp75, mAb 16H3 also binds approximately 20 distinct nuclear proteins in human, frog, and Drosophila extracts, whereas yeast do not detectably express the epitope. The antigens are shown to be nuclear, nonnucleolar, and concentrated at active sites of RNA polymerase II transcription which suggests their involvement in pre-mRNA processing. Indeed, most of the reactive proteins observed in nuclear extract are detected in spliceosomes (E and/or B complex) assembled in vitro, including the U1 70K component of the U1 small nuclear ribonucleoprotein particle and both subunits of U2AF. Interestingly, the 16H3 epitope was mapped to a 40-amino acid polypeptide composed almost exclusively of arginine alternating with glutamate and aspartate. All of the identified antigens, including the human homolog of yeast Prp22 (HRH1), contain a similar structural element characterized by arginine alternating with serine, glutamate, and/or aspartate. These results indicate that many more spliceosomal components contain such arginine-rich domains. Because it is conserved among metazoans, we propose that the "alternating arginine" domain recognized by mAb 16H3 may represent a common functional element of pre-mRNA splicing factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538140      PMCID: PMC2120486          DOI: 10.1083/jcb.129.4.899

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  49 in total

1.  Cloning and domain structure of the mammalian splicing factor U2AF.

Authors:  P D Zamore; J G Patton; M R Green
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

2.  RNA recognition: towards identifying determinants of specificity.

Authors:  D J Kenan; C C Query; J D Keene
Journal:  Trends Biochem Sci       Date:  1991-06       Impact factor: 13.807

3.  An ATP-independent complex commits pre-mRNA to the mammalian spliceosome assembly pathway.

Authors:  S Michaud; R Reed
Journal:  Genes Dev       Date:  1991-12       Impact factor: 11.361

4.  Immunofluorescent techniques in the analysis of chromosomal proteins.

Authors:  L M Silver; C E Wu; S C Elgin
Journal:  Methods Cell Biol       Date:  1978       Impact factor: 1.441

5.  Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity.

Authors:  P B Billings; R W Allen; F C Jensen; S O Hoch
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

6.  Correlation of hnRNP structure and nascent transcript cleavage.

Authors:  A L Beyer; A H Bouton; O L Miller
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Identification of a putative RNA helicase (HRH1), a human homolog of yeast Prp22.

Authors:  Y Ono; M Ohno; Y Shimura
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

9.  RNA polymerase B in polytene chromosomes: immunofluorescent and autoradiographic analysis during stimulated and repressed RNA synthesis.

Authors:  H Sass
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

10.  A conserved family of nuclear phosphoproteins localized to sites of polymerase II transcription.

Authors:  M B Roth; A M Zahler; J A Stolk
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

View more
  35 in total

1.  Identification and characterization of a novel serine-arginine-rich splicing regulatory protein.

Authors:  D C Barnard; J G Patton
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  The 100-kda U5 snRNP protein (hPrp28p) contacts the 5' splice site through its ATPase site.

Authors:  N Ismaïli; M Sha; E H Gustafson; M M Konarska
Journal:  RNA       Date:  2001-02       Impact factor: 4.942

3.  Sensitivity of splice sites to antisense oligonucleotides in vivo.

Authors:  H Sierakowska; M J Sambade; D Schümperli; R Kole
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

4.  Coupled in vitro synthesis and splicing of RNA polymerase II transcripts.

Authors:  S Ghosh; M A Garcia-Blanco
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

5.  The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5' splice sites.

Authors:  Patrik Förch; Oscar Puig; Concepción Martínez; Bertrand Séraphin; Juan Valcárcel
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

6.  The C-terminal domain of the largest subunit of RNA polymerase II interacts with a novel set of serine/arginine-rich proteins.

Authors:  A Yuryev; M Patturajan; Y Litingtung; R V Joshi; C Gentile; M Gebara; J L Corden
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

7.  RNA splicing capability of live neuronal dendrites.

Authors:  J Glanzer; K Y Miyashiro; J-Y Sul; L Barrett; B Belt; P Haydon; J Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

8.  Identification of the factors that interact with NCBP, an 80 kDa nuclear cap binding protein.

Authors:  N Kataoka; M Ohno; I Moda; Y Shimura
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

9.  A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly.

Authors:  Z M Zheng; M Huynen; C C Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  The mammalian homologue of Prp16p is overexpressed in a cell line tolerant to Leflunomide, a new immunoregulatory drug effective against rheumatoid arthritis.

Authors:  D Ortlepp; B Laggerbauer; S Müllner; T Achsel; B Kirschbaum; R Lührmann
Journal:  RNA       Date:  1998-08       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.